Flow MedTech is developing an implantable device that minimizes the risk of stroke for individuals suffering from an irregular heart rhythm, called atrial fibrillation. The technology aims to lower the need for blood thinners, which can reduce the bleeding risk in patients. Flow MedTech is currently in the testing phase of the device and in the process of pursuing FDA approval. Our competitive advantages include custom fit, being recapturable, and ease of implantation. The mission of Flow MedTech is to reduce the risk of stroke for those with atrial fibrillation by using a safe, implantable device, and improve patient quality of life.